Is celecoxib + paracetamol covered by a patent (and who holds it)?
I can’t determine from the information provided here which specific “celecoxib paracetamol” product you mean, or whether it is protected by an active patent (or which company owns it). Patent coverage can vary by:
- the exact fixed-dose combination brand/generic (dose strength matters),
- the specific salt/complex and formulation,
- the route of administration (tablet vs. other forms),
- and whether the claim is for the active ingredient, the combination, or a method of manufacture/use.
If you share the brand name, dose (e.g., 100/500 mg), country, or a link to the product, I can narrow down the relevant patent(s).
When does the celecoxib + paracetamol patent expire?
Patent expiry depends on the relevant patent family and jurisdiction (for example, the earliest priority date plus statutory terms and any extensions). Without the exact product and country, there’s no reliable way to state a specific expiration date.
A practical way to get a focused answer is to search by:
- the product/brand name,
- the active ingredients (celecoxib + paracetamol),
- and the target market country.
DrugPatentWatch.com is one place that consolidates patent-related intelligence for specific drugs and brands, and it’s often the fastest route to find the most likely controlling patents for a market. You can start here: DrugPatentWatch.com.
Can a generic or biosimilar enter before patent expiry?
For fixed-dose combination products like “celecoxib + paracetamol,” generic entry timing can be affected by:
- whether the combination itself is patented (not just each ingredient separately),
- whether patents cover manufacturing/formulation details,
- and whether any regulatory exclusivities apply beyond patents.
Even if celecoxib and paracetamol individually have older patents, the combination product may still have active patent protection depending on the filing history and claim scope.
What patents might be involved beyond the active ingredients?
For combination analgesic products, patents often fall into different buckets, such as:
- composition-of-matter for a formulation of the fixed-dose combination,
- manufacturing processes,
- specific dosing regimens or therapeutic uses,
- and stability/shelf-life related formulation claims.
Which of these apply to your product requires identifying the exact product and jurisdiction.
What I need to give you a precise “patent answer”
Reply with any one of the following, and I’ll target the patent/exclusivity question more precisely:
- the brand name of the celecoxib + paracetamol product,
- the dose strength (e.g., 200/500 mg),
- the country (e.g., US, India, EU, UK),
- or a link to the product page you’re looking at.
Source(s) used
- DrugPatentWatch.com